Select Medical stockholders approved the acquisition by a consortium led by Robert Ortenzio, Martin Jackson, and WCAS. The approval finalizes stockholder consent, moving the deal forward toward an expected mid-2026 closing.
Select Medical stockholders approved the acquisition by a consortium led by Robert Ortenzio, Martin Jackson, and WCAS. The approval finalizes stockholder consent, moving the deal forward toward an expected mid-2026 closing.